J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS)
INR 1568.1
(-1.43%)
INR 1568.1
(-1.43%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.79 Billion INR | -42.57% |
| 2022 | 13.99 Billion INR | 28.86% |
| 2021 | 10.86 Billion INR | 35.62% |
| 2020 | 8 Billion INR | 3.96% |
| 2019 | 7.7 Billion INR | 5.46% |
| 2018 | 7.3 Billion INR | 10.43% |
| 2017 | 6.61 Billion INR | 15.28% |
| 2016 | 5.73 Billion INR | 14.6% |
| 2015 | 5 Billion INR | 9.55% |
| 2014 | 4.57 Billion INR | 10.2% |
| 2013 | 4.14 Billion INR | 17.64% |
| 2012 | 3.52 Billion INR | 8.03% |
| 2011 | 3.26 Billion INR | -22.63% |
| 2010 | 4.21 Billion INR | -29.23% |
| 2009 | 5.96 Billion INR | -11.58% |
| 2008 | 6.74 Billion INR | 32.11% |
| 2007 | 5.1 Billion INR | 12.12% |
| 2006 | 4.55 Billion INR | 17.1% |
| 2005 | 3.88 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.17 Billion INR | 3.2% |
| 2023 Q1 | 3.85 Billion INR | 8.4% |
| 2023 Q4 | 2.1 Billion INR | -44.83% |
| 2023 Q2 | 3.72 Billion INR | -3.45% |
| 2023 Q3 | 3.81 Billion INR | 2.58% |
| 2023 FY | 8.03 Billion INR | -42.57% |
| 2022 Q3 | 3.47 Billion INR | -1.17% |
| 2022 Q1 | 3.45 Billion INR | 21.3% |
| 2022 FY | 13.99 Billion INR | 28.86% |
| 2022 Q4 | 3.55 Billion INR | 2.39% |
| 2022 Q2 | 3.51 Billion INR | 1.76% |
| 2021 Q4 | 2.84 Billion INR | 0.43% |
| 2021 Q3 | 2.83 Billion INR | 3.28% |
| 2021 Q2 | 2.74 Billion INR | 12.67% |
| 2021 Q1 | 2.43 Billion INR | 36.66% |
| 2021 FY | 10.86 Billion INR | 35.62% |
| 2020 FY | 8 Billion INR | 3.96% |
| 2020 Q2 | 2.17 Billion INR | 9.69% |
| 2020 Q3 | 2.07 Billion INR | -4.31% |
| 2020 Q4 | 1.78 Billion INR | -14.18% |
| 2020 Q1 | 1.97 Billion INR | 23.67% |
| 2019 Q1 | 1.99 Billion INR | 47.51% |
| 2019 Q2 | 2.05 Billion INR | 3.34% |
| 2019 Q4 | 1.6 Billion INR | -22.11% |
| 2019 FY | 7.7 Billion INR | 5.46% |
| 2019 Q3 | 2.05 Billion INR | -0.19% |
| 2018 Q3 | 1.92 Billion INR | -7.99% |
| 2018 Q2 | 2.09 Billion INR | 19.62% |
| 2018 Q1 | 1.74 Billion INR | 0.0% |
| 2018 FY | 7.3 Billion INR | 10.43% |
| 2018 Q4 | 1.35 Billion INR | -29.79% |
| 2017 Q1 | 1.55 Billion INR | 6.94% |
| 2017 FY | 6.61 Billion INR | 15.28% |
| 2016 FY | 5.73 Billion INR | 14.6% |
| 2016 Q4 | 1.45 Billion INR | 0.0% |
| 2015 FY | 5 Billion INR | 9.55% |
| 2015 Q4 | 1.25 Billion INR | 0.0% |
| 2014 FY | 4.57 Billion INR | 10.2% |
| 2013 Q1 | 976.72 Million INR | 0.0% |
| 2013 FY | 4.14 Billion INR | 17.64% |
| 2012 Q1 | 830.78 Million INR | 0.0% |
| 2012 FY | 3.52 Billion INR | 8.03% |
| 2011 FY | 3.26 Billion INR | -22.63% |
| 2010 FY | 4.21 Billion INR | -29.23% |
| 2009 FY | 5.96 Billion INR | -11.58% |
| 2008 FY | 6.74 Billion INR | 32.11% |
| 2007 FY | 5.1 Billion INR | 12.12% |
| 2006 FY | 4.55 Billion INR | 17.1% |
| 2005 FY | 3.88 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -103977.549% |
| Aarti Drugs Limited | 1.16 Billion INR | -1167.05% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -381.152% |
| Ajanta Pharma Limited | 30.46 Billion INR | 51.44% |
| Alembic Limited | 872.45 Million INR | -1595.502% |
| Alkem Laboratories Limited | 32.83 Billion INR | 54.949% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 6.788% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -498.041% |
| Bal Pharma Limited | 555.62 Million INR | -2562.32% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -216799.443% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -942.299% |
| Brooks Laboratories Limited | 51.18 Million INR | -28802.974% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -3146.934% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -580.273% |
| Divi's Laboratories Limited | 14.17 Billion INR | -4.393% |
| Eris Lifesciences Limited | 4.94 Billion INR | -199.266% |
| Granules India Limited | 10.31 Billion INR | -43.439% |
| Ind-Swift Limited | 946.56 Million INR | -1462.757% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -3273.057% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -2.342% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -3486.706% |
| Medicamen Biotech Limited | 335.16 Million INR | -4313.484% |
| Medico Remedies Limited | 59.67 Million INR | -24688.508% |
| Wockhardt Limited | 8.48 Billion INR | -74.44% |
| Orchid Pharma Limited | 800.77 Million INR | -1747.287% |
| RPG Life Sciences Limited | 1.63 Billion INR | -804.466% |
| Shilpa Medicare Limited | 3.33 Billion INR | -343.664% |
| Sigachi Industries Limited | 579.88 Million INR | -2450.935% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -479.168% |
| Unichem Laboratories Limited | 6.72 Billion INR | -119.935% |
| Vaishali Pharma Limited | 84.02 Million INR | -17504.091% |
| Wanbury Limited | 978.96 Million INR | -1411.037% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 88.186% |
| FDC Limited | 3.49 Billion INR | -322.673% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -606.413% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1401.255% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 84.571% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -27.076% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -596.387% |
| Laurus Labs Limited | 11.9 Billion INR | -24.205% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -9018.366% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1485.991% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -25278.358% |
| Hester Biosciences Limited | 908.84 Million INR | -1527.629% |
| Ipca Laboratories Limited | 18.98 Billion INR | 22.094% |
| Venus Remedies Limited | 1.91 Billion INR | -671.939% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1360.187% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 73.422% |
| Morepen Laboratories Limited | 1.98 Billion INR | -644.298% |
| Neuland Laboratories Limited | 2.92 Billion INR | -404.909% |
| Sequent Scientific Limited | 2.9 Billion INR | -409.769% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -954.509% |
| Valiant Laboratories Limited | 138.02 Million INR | -10616.981% |
| Windlas Biotech Limited | 1 Billion INR | -1369.687% |
| Hikal Limited | 4.46 Billion INR | -231.389% |
| Innova Captab Limited | 931.03 Million INR | -1488.836% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -393.842% |
| Themis Medicare Limited | 1.12 Billion INR | -1213.961% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -572.083% |
| Mankind Pharma Limited | 29.27 Billion INR | 49.467% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 68.495% |
| Sakar Healthcare Limited | 204.07 Million INR | -7148.439% |
| Albert David Limited | 1.02 Billion INR | -1341.562% |
| Lupin Limited | 125.09 Billion INR | 88.175% |
| Gufic Biosciences Limited | 1.18 Billion INR | -1146.644% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 90.406% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1277.093% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -4179.841% |
| Piramal Enterprises Limited | 63.65 Billion INR | 76.761% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 30.947% |
| NATCO Pharma Limited | 10.05 Billion INR | -47.072% |
| Suven Life Sciences Limited | 109.75 Million INR | -13378.398% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -31949.012% |
| Strides Pharma Science Limited | 9.16 Billion INR | -61.45% |
| Indoco Remedies Limited | 12.06 Billion INR | -22.646% |
| Alpa Laboratories Limited | 127.38 Million INR | -11512.924% |
| Lasa Supergenerics Limited | 291.17 Million INR | -4980.31% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -380.777% |